Despite declining rates of CRC for the U.

Colorectal malignancy incidence increasing among adults The incidence of colorectal cancer among young adults ages 20-39 years has increased during the past 20-30 years, despite declining rates of CRC for the U.S. Human population overall site . This surprising brand-new finding, an analysis of how CRC incidence varies based on race and gender, and differences in tumor location, symptoms, and survival for young adults compared to the general population are provided in Journal of Adolescent and Young Adult Oncology , a multidisciplinary peer-reviewed publication from Mary Ann Liebert, Inc., publishers. Until February 22 This article is available free of charge on the JAYAO website, 2015. Related StoriesOvarian malignancy patients with a history of oral contraceptive make use of have better outcomesCornell biomedical engineers develop 'super natural killer cells' to destroy cancer cells in lymph nodesMeat-rich diet may increase kidney cancer riskIn this article ‘Colorectal Tumor Incidence Among Young Adults in California’, Kathryn Singh, MPH, MS, Thomas Taylor, PhD, Chuan-Ju Pan, MD, Michael Stamos, MD, and Jason Zell, DO, MPH, University of California, Irvine, analyzed more than 231,500 CRC cases over a 22-12 months period, including 5,617 cases affecting adults.

Colorectal cancer survivors at greater risk of developing second cancer: Study Colorectal cancers survivors face an increased risk of developing subsequent cancers, second colorectal cancers and little intestinal cancers particularly. That is the conclusion of a fresh study published early on-line in Cancer tumor, a peer-reviewed journal of the American Cancer tumor Society. The findings may help in the advancement of screening recommendations for patients with a brief history of colorectal cancer. Studies have found that colorectal cancers survivors have a greater threat of developing another malignancy compared with the general people. Amanda Phipps, PhD, MPH, of the University of Washington and Fred Hutchinson Cancers Research Center in Seattle, and her co-workers looked to observe whether that elevated risk differed for folks based on where their previous cancer was located within the colon or rectum.